Holdings of iShares Genomics Immunology and Healthcare ETF
iShares Trust · 50 declared positions · as of Apr 30, 2026
Original filing · Net assets 160.5M $ · Ten largest lines: 49.2 % of the equity sleeve
Country breakdown
Shares computed on the equity sleeve, the only part this site carries.
| Country | Lines | Value (USD) | Share |
|---|---|---|---|
| US | 33 | 92.8M $ | 60.80 % |
| FR | 3 | 14.9M $ | 9.74 % |
| JP | 2 | 9.8M $ | 6.40 % |
| CH | 2 | 9.3M $ | 6.10 % |
| DE | 1 | 7M $ | 4.60 % |
| GB | 1 | 6.6M $ | 4.34 % |
| DK | 1 | 5.1M $ | 3.33 % |
| HK | 2 | 2.9M $ | 1.92 % |
| CA | 1 | 1.7M $ | 1.12 % |
| CN | 2 | 1M $ | 0.67 % |
| KR | 1 | 903.7K $ | 0.59 % |
| IS | 1 | 629.2K $ | 0.41 % |
Sector breakdown is published in no regulatory filing: neither Form N-PORT nor the LEI reference data carries an activity code. It is absent rather than estimated.
Positions
| Company | Shares | Value (USD) | Weight |
|---|---|---|---|
| Revolution Medicines Inc | 76,325 | 11M $ | 6.85 % |
| Moderna Inc | 219,441 | 10.1M $ | 6.28 % |
| Ipsen SA | 42,810 | 8.4M $ | 5.24 % |
| Bayer AG | 156,689 | 7M $ | 4.38 % |
| Takeda Pharmaceutical Co Ltd | 202,500 | 6.8M $ | 4.22 % |
| Merck & Co Inc | 60,956 | 6.7M $ | 4.15 % |
| GSK PLC | 252,397 | 6.6M $ | 4.12 % |
| Roche Holding AG | 15,724 | 6.4M $ | 3.99 % |
| Exelixis Inc | 137,027 | 6.1M $ | 3.80 % |
| Twist Bioscience Corp | 103,936 | 6.1M $ | 3.79 % |
| Regeneron Pharmaceuticals, Inc. | 8,462 | 6M $ | 3.73 % |
| Sanofi SA | 61,394 | 5.7M $ | 3.58 % |
| Vertex Pharmaceuticals Inc | 13,345 | 5.7M $ | 3.55 % |
| Incyte Corp | 59,291 | 5.6M $ | 3.52 % |
| Genmab A/S | 19,182 | 5.1M $ | 3.16 % |
| Ideaya Biosciences Inc | 149,434 | 4.3M $ | 2.71 % |
| ImmunityBio Inc | 589,940 | 4.2M $ | 2.61 % |
| Caris Life Sciences Inc | 205,671 | 3.9M $ | 2.44 % |
| Arcus Biosciences Inc | 133,599 | 3.4M $ | 2.12 % |
| Ono Pharmaceutical Co Ltd | 202,300 | 3M $ | 1.86 % |
| CRISPR Therapeutics AG | 55,336 | 2.9M $ | 1.80 % |
| Novavax Inc | 264,512 | 2.1M $ | 1.31 % |
| Iovance Biotherapeutics Inc | 593,884 | 2M $ | 1.24 % |
| GenFleet Therapeutics Shanghai Inc | 345,600 | 1.9M $ | 1.20 % |
| Nuvation Bio Inc | 426,642 | 1.9M $ | 1.18 % |
| Vir Biotechnology Inc | 167,572 | 1.7M $ | 1.07 % |
| AbCellera Biologics Inc | 411,289 | 1.7M $ | 1.06 % |
| Corvus Pharmaceuticals Inc | 102,168 | 1.6M $ | 0.97 % |
| Janux Therapeutics Inc | 95,943 | 1.4M $ | 0.86 % |
| Kura Oncology Inc | 150,470 | 1.3M $ | 0.83 % |
| Sunshine Lake Pharma Co Ltd | 190,700 | 1M $ | 0.62 % |
| CytomX Therapeutics Inc | 228,039 | 962.3K $ | 0.60 % |
| Ocugen Inc | 548,690 | 949.2K $ | 0.59 % |
| Rigel Pharmaceuticals Inc | 31,513 | 910.7K $ | 0.57 % |
| AbClon Inc. | 27,030 | 903.7K $ | 0.56 % |
| Intellia Therapeutics Inc | 66,593 | 897.7K $ | 0.56 % |
| Shanghai Henlius Biotech Inc | 83,900 | 805.6K $ | 0.50 % |
| Pacific Biosciences of California Inc | 483,024 | 768K $ | 0.48 % |
| Design Therapeutics Inc | 55,761 | 758.3K $ | 0.47 % |
| Valneva SE | 258,253 | 705.4K $ | 0.44 % |
| Ginkgo Bioworks Holdings Inc | 75,293 | 637K $ | 0.40 % |
| Verastem Inc | 116,276 | 634.9K $ | 0.40 % |
| Alvotech SA | 188,379 | 629.2K $ | 0.39 % |
| Personalis Inc | 94,670 | 522.6K $ | 0.33 % |
| Xencor Inc | 40,644 | 484.9K $ | 0.30 % |
| Guangzhou Innogen Pharmaceutical Group Co Ltd | 120,200 | 214.8K $ | 0.13 % |
| Prime Medicine Inc | 56,846 | 201.5K $ | 0.13 % |
| ARCELLX INC CVR | 73,059 | 5.1K $ | 0.00 % |
| OmniAb Inc | 19,498 | 0.2 $ | |
| OmniAb Inc | 19,498 | 0.2 $ |